Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?

Patel Jyoti D.; Chmura Steven J.

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?

【24h】

Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?

机译：III期非小细胞肺癌的标准治疗的免疫检查点抑制部分吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2018年第14期|共4页
作者
Patel Jyoti D.; Chmura Steven J.;
展开▼
作者单位

Section of Hematology/Oncology Department of MedicineThe University of ChicagoIllinois;

Department of Radiation OncologyThe University of ChicagoIllinois;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer? [J] . Patel Jyoti D., Chmura Steven J. Cancer: A Journal of the American Cancer Society . 2018,第14期

机译：III期非小细胞肺癌的标准治疗的免疫检查点抑制部分吗？
2. Correction: Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study,Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (N [J] . BMJ Open . 2016,第7期

机译：更正：III期非小细胞肺癌（NSCLC）等毒性调强放射疗法（IMRT）的方案：一项可行性研究，III期非小细胞肺癌（N）等毒性调强放射疗法（IMRT）的协议
3. Immune-checkpoint inhibitors plus chemotherapy versus chemotherapy as first-line treatment for patients with extensive-stage small cell lung cancer [J] . Fei Zhou, Wencheng Zhao, Xiaomei Gong, Journal for ImmunoTherapy of Cancer . 2020,第2期

机译：免疫检查点抑制剂加上化疗与化疗作为广泛阶段小细胞肺癌患者的一线治疗
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. A Study of Erlotinib Monotherapy and in Combination with Pembrolizumab in Previously Untreated Stage I-IIIA Non-small Cell Lung Cancer [D] . Liu, Qiong. 2021

机译：Erlotinib单疗法和蛋白质在先前未处理阶段I-IIIA非小细胞肺癌中的研究
6. Advances in immunotherapy for stage III non-small cell lung cancer: moving immune checkpoint inhibitors to the front lines concurrently with chemoradiotherapy? [O] . Toyoaki Hida, Teppei Yamaguchi 2020

机译：III阶段非小细胞肺癌免疫疗法的进展：将免疫检查点抑制剂与化学疗法同时移动到前线？
7. Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer? [O] . Jyoti D. Patel, Steven J. Chmura 2018

机译：III期非小细胞肺癌的标准治疗的免疫检查点抑制部分吗？
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Is immune checkpoint inhibition part of standard therapy for stage III non‐small cell lung cancer?

著录项

相似文献

相关主题

期刊订阅